These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36258171)

  • 21. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Out of proportion pulmonary hypertension in obstructive lung diseases.
    Chatterjee K; Tarawneh AR; Alam S
    Curr Opin Pulm Med; 2018 Mar; 24(2):161-172. PubMed ID: 29256906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
    Gershon AS; Campitelli MA; Croxford R; Stanbrook MB; To T; Upshur R; Stephenson AL; Stukel TA
    JAMA; 2014 Sep; 312(11):1114-21. PubMed ID: 25226477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary Hypertension in COPD: A Case Study and Review of the Literature.
    Cassady SJ; Reed RM
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31382489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease Burden of Patients with Asthma/COPD Overlap in a US Claims Database: Impact of ICD-9 Coding-based Definitions.
    Wurst KE; St Laurent S; Hinds D; Davis KJ
    COPD; 2017 Apr; 14(2):200-209. PubMed ID: 28103123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts.
    Gladue H; Steen V; Allanore Y; Saggar R; Saggar R; Maranian P; Berrocal VJ; Avouac J; Meune C; Trivedi M; Khanna D
    J Rheumatol; 2013 Oct; 40(10):1706-11. PubMed ID: 23950183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
    Lipworth B; Skinner D; Devereux G; Thomas V; Ling Zhi Jie J; Martin J; Carter V; Price DB
    Heart; 2016 Dec; 102(23):1909-1914. PubMed ID: 27380949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Echocardiography and pulmonary hypertension in patients with chronic obstructive pulmonary disease undergoing lung transplantation evaluation.
    Younis M; Al-Antary N; Dalbah R; Qarajeh A; Khanfar AN; Kar AA; Reddy R; Alzghoul BN
    Am J Med Sci; 2024 Feb; 367(2):95-104. PubMed ID: 37967751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burden of pulmonary hypertension due to chronic obstructive pulmonary disease: Analysis of exacerbations and healthcare resource utilization in the United States.
    Klinger JR; Wu B; Morland K; Classi P; Fiano R; Grabich S
    Respir Med; 2023; 219():107412. PubMed ID: 37729954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends and Factors Associated with Nebulized Therapy Prescription in Older Adults with Chronic Obstructive Pulmonary Disease from 2008 to 2015.
    Singh M; Duarte AG; Hsu ES; Kuo YF; Sharma G
    J Aerosol Med Pulm Drug Deliv; 2020 Jun; 33(3):161-169. PubMed ID: 32017642
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary arterial hypertension.
    Montani D; Günther S; Dorfmüller P; Perros F; Girerd B; Garcia G; Jaïs X; Savale L; Artaud-Macari E; Price LC; Humbert M; Simonneau G; Sitbon O
    Orphanet J Rare Dis; 2013 Jul; 8():97. PubMed ID: 23829793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.
    Mapel D; Laliberté F; Roberts MH; Sama SR; Sundaresan D; Pilon D; Lefebvre P; Duh MS; Patel J
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1825-1836. PubMed ID: 28684905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.
    Ruopp NF; Cockrill BA
    JAMA; 2022 Apr; 327(14):1379-1391. PubMed ID: 35412560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.
    Thakkar V; Stevens W; Prior D; Youssef P; Liew D; Gabbay E; Roddy J; Walker JG; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
    Arthritis Res Ther; 2013; 15(6):R193. PubMed ID: 24246100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study.
    Deaño RC; Glassner-Kolmin C; Rubenfire M; Frost A; Visovatti S; McLaughlin VV; Gomberg-Maitland M
    JAMA Intern Med; 2013 May; 173(10):887-93. PubMed ID: 23568223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effect of vasodilator therapy in pulmonary hypertension due to COPD: a retrospective analysis.
    Fossati L; Müller-Mottet S; Hasler E; Speich R; Bloch KE; Huber LC; Ulrich Somaini S
    Lung; 2014 Dec; 192(6):987-95. PubMed ID: 25348430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary hypertension associated with COPD.
    Elwing J; Panos RJ
    Int J Chron Obstruct Pulmon Dis; 2008; 3(1):55-70. PubMed ID: 18488429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.